Cancer

News

AZ grabs EU approval for Imfinzi in advanced lung cancer

The European Commission has approved AstraZeneca’s immunotherapy drug Imfinzi (durvalumab) in a kind of lung cancer that was previously only treatable with chemotherapy.

News

Merck and Pfizer trial cancer combination with Australia's I...

Australian biotech Immutep has begun a clinical trial partnership with Germany’s Merck KGaA and Pfizer to develop a new cancer immunotherapy combination therapy.

News

Roche aims to improve cancer treatments with DNA blood test

Roche has launched a blood test that can identify 70 of the most commonly mutated genes in solid tumours, as the company seeks to make more medicine more personalised.

News

Novartis, Bayer consider appeal as court says Avastin can be...

England’s High Court has ruled it is lawful to use Roche’s Avastin (bevacizumab) in an unlicensed use in wet age-related macular degeneration (AMD) instead of more expensive approved drugs

Partner Content

Partner Content

Immuno-Oncology 2018 News: MHRA Interview and New Speaker Im...

Just Over 1 Week Until Immuno-Oncology 2018 Commences

News

NICE rejects Novartis' CAR-T in adult lymphoma

NICE has said Novartis’ CAR-T therapy Kymriah cannot be funded by the NHS in adults with an aggressive form of lymphoma, calling for further discussions to get the drug on to the market.

AZ grabs EU approval for Imfinzi in advanced lung cancer

Merck and Pfizer trial cancer combination with Australia's I...

Roche aims to improve cancer treatments with DNA blood test

Novartis, Bayer consider appeal as court says Avastin can be...

Immuno-Oncology 2018 News: MHRA Interview and New Speaker Im...

NICE rejects Novartis' CAR-T in adult lymphoma

AI-enabled pharmacovigilance, with Updesh Dosanjh

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks